Mount Sinai identifies drugs that
could prevent COVID-19 replication
|
|
Unlike other
research to repurpose drugs to treat infection, this effort focused on
inhibiting viral uptake of SARS-CoV-2 in the first place.
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Thursday, September 3, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment